The China National Medical Products Administration (NMPA) has joined the International Medical Device Regulators Forum’s (IMDRF) national competent authority report (NCAR) exchange program. NCAR

supports the global distribution of post-market safety information in an attempt to stop medical devices from causing serious harm to patients. Currently, more than 20 countries and regions have joined the cooperation mechanism.

NMPA joined the program to shared details of its involvement with NCAR on the same day as it provided an update on its other work with IMDRF. At an IMDRF meeting last week, attendees approved guidance prepared by NMPA. The approval marked the first time IMDRF had approved guidance prepared by the Chinese regulatory agency.